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The presence of valuable bioactive molecules in plant alkaloids renders isoquinoline 
alkaloid biosynthesis one of the most focused targets for metabolic engineering as well 
as chemical synthesis. However, due to the lack of an effective, rapid and broad-based 
bioactivity screening tool, many of these alkaloids remained unexplored for the 
development of novel pharmaceutical compounds. Research into the molecular and 
developmental biology of Caenorhabditis elegans was begun in 1965 by Sydney 
Brenner and it has since been used extensively as a model organism. This worm model 
offers several distinct advantages including low running cost, ease of manipulation and 
short generation time which allows rapid experimentation. The completion of C. 
elegans genome sequencing revealed that many important biological processes are 
evolutionarily conserved between human and the worm; thus making this worm a 
popular model to study drug-target interaction and target validation. 
In this study, C. elegans was used as a whole organism model to screen for 
biological activities of isoquinoline alkaloids. Chapter I describes the screening of 
isoquinoline alkaloids for lipid reducing activities. Using berberine as a reference 
compound which was reported to exhibit triglycerides- and cholesterol-lowering 
properties, worms were stained with Nile Red and Oil Red O stain to observe changes 
in lipid accumulation in vivo. Among the several classes of isoquinoline alkaloids tested, 
only berberine and sanguinarine were found to be lipid metabolism modulators, with 
sanguinarine showing more potent lipid-reducing activity at 20-fold lower concentration. 
Further investigation was carried out on the involvement of AMPK and transcription 
factors in the lipid metabolism pathway responsible for the lipid reduction activity upon 
berberine and sanguinarine treatment. Immunoblotting revealed AMPK activation in 
berberine- and sanguinarine-treated worms. RNAi experiments further showed 
involvement of AAK-2, the C. elegans homologs of the catalytic -subunits of AMPK, 
in the lipid-reducing effect of berberine and sanguinarine. On the other hand, this effect 
was found to be independent on NHR-49, a hormone nuclear receptor gene that 
functions as key regulator of fat consumption. These results suggest that the alkaloids’ 
lipid reducing effect predominantly affect lipid synthesis, rather than fatty acid -
oxidation. 
  
In Chapter II, the worm model was applied to screen extracts from metabolically 
engineered plant cell cultures for synergistic bioactivities in plant alkaloids. As known 
in the case of most ethnobotanical or traditional medicine applications, it is a concoction 
of plant extracts that produced therapeutic effects. The lipid reducing effect was 
compared to that observed in single compounds. The lipid reducing effect of Coptis 
japonica cell culture extract showed higher activity than berberine at similar 
concentration. However, extract from an Eschscholzia californica cell culture required 
higher concentration of sanguinarine than in single compound treatment. This shows 
that cell extracts contain both synergistic and antagonistic components that may lead to 
differences in the bioactivity strength compared to single alkaloids. 
The function of plant alkaloids has been suggested as defense against herbivores and 
pathogens, therefore they are likely to induce xenobiotic response and consequently 
their bioavailability might be reduced in vivo. Accordingly, the isoquinoline alkaloids, 
berberine and sanguinarine, were also expected to induce xenobiotics response in the 
worms. Chapter III describes an attempt to enhance the sensitivity of the worm 
screening system and to minimize the effective concentration of test compounds needed 
for bioactivity assays. The detoxification response in C. elegans was impeded by 
knocking down nhr-8, a gene encoding a nuclear hormone receptor which is involved in 
xenobiotic resistance response. nhr-8 RNAi worms were found to be more susceptible 
to the lipid reduction effects of some isoquinoline alkaloids, especially berberine which 
could reduce lipid accumulation at about 8-fold lower concentration than in wild-type 
worms. The nhr-8 RNAi worms were expected to accumulate more alkaloids when the 
detoxification response was knocked down but the results showed that it occurred only 
at low dosages. It is plausible that the lower, sub-lethal alkaloids dosages would trigger 
the defense response genes to a moderate level that NHR-8 knockdown was effective to 
suppress such response and resulted in higher alkaloid accumulation in the nhr-8 RNAi 
worms. Although enhanced sensitivity of the nhr-8 RNAi worms was expected to have 
suppressed detoxification mechanism, the major upregulated detoxification genes were 
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Alkaloids are natural occurring, low molecular weight, nitrogenous secondary 
metabolites found in about 20% of flowering plant species and many among them were 
reported to exhibit potent pharmacological activities. There are increasingly extensive 
investigations on the therapeutic effects of these plant natural chemicals for drug 
applications. For this purpose, a rapid and broad-based bioassay system is ideal for the 
preliminary screen. 
In this study, Caenorhabditis elegans was used as a screening model to detect 
biological activities of isoquinoline alkaloids since it has many advantageous features as 
preliminary screen in terms of cost, time and ease of manipulation (Corsi, 2006). It is 
relatively inexpensive to cultivate worms for use in the lab. Due to its small size, the 
worm is easy to physically manipulate and most assays can be carried out in microtitre 
or agar plates. Its average lifespan of three weeks is advantageous for lifespan and 
ageing studies. About 40% of the genes associated with human diseases have homologs 
in the C. elegans genome, making it a good model for drug development research. In 
fact, the popularity of C. elegans as a model for drug discovery is evident by the amount 
of published work on chemistry-to-gene, gene-to-drug screen using this nematode (Link 
et al., 2000; Kaletta and Hengartner, 2006; Burns et al., 2010). Genes do not work in 
isolation to generate particular phenotypes, rather they interact with other genes and are 
influenced by the environment, therefore using whole-animal invertebrate models, such 
as C. elegans, have proven to be useful in these endeavours. Besides, an intact animal 
has advantage over in-vitro or cell-based assays as many compounds that exhibit 
bioactivities fail to show efficacy when applied to whole animal (Stelling et al., 2004; 
Knight et al., 2007). As model organism, C. elegans also offers physiological 
advantages such as rapid reproduction cycle and transparent body wall which enable the 
use of in vivo fluorescence markers and stains to study processes such as axon growth, 
embryogenesis and fat metabolism in the worm. 
In the preliminary experiment, worms were treated with isoquinoline alkaloids to 
screen for lipid-modulating activity.  Although the mammalian regulatory pathways 
involving energy homeostasis are more sophisticated than those of C. elegans, the core 
mechanisms are largely conserved. Lemieux et al. (2011) also indicated the usefulness 
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of C. elegans in screening small molecules to identify new regulators of fat storage. 
Berberine, a benzylisoquinoline alkaloid commonly used as an antibacterial agent for 
gut infection and diarrhea, has recently been reported to show triglycerides and plasma 
cholesterol-lowering effects and improved insulin action in high-fat-fed rats. Using 
berberine as a reference compound, the lipid reduction effect of alkaloids in the worm 
was examined using staining method with Nile Red and Oil Red O. Potent lipid 
metabolism modulators identified from the preliminary screen were further investigated 
on their action mechanisms. Recent reports suggested activation of AMP-activated 
protein kinase (AMPK) by berberine is responsible for its lipid-reducing effect. As there 
are various types of AMPK activator and also various mechanisms for AMPK 
activation (Hawley et al., 2010), further investigation was carried out on the 
involvement of AMPK and transcription factors in the lipid metabolism pathway 
responsible for the lipid reduction of alkaloids using immunoblotting and RNA 
interference methods. 
In traditional medicine applications, extracts that contain a mixture of active 
components are usually used to yield therapeutic effect. Unlike harvesting medicinal 
plants from the field which is limited in supply and time-consuming, one possible way 
to enhance production is through metabolic engineering. Metabolic engineering of plant 
secondary metabolites biosynthesis pathway could improve quality of metabolites by 
reducing undesired pathways, introducing new pathways to produce novel compounds, 
or by completely blocking a pathway to accumulate intermediates. In addition to 
screening single alkaloids, the established C. elegans screening system was next applied 
to screen for synergistic lipid modulating activity of metabolically engineered plant cell 
culture extracts. 
Recent studies on C. elegans have identified many genes encoding sensors and 
enzymes that the worms may use in their xenobiotics responses such as a large number 
of four main classes of detoxification enzymes including cytochromes P450, short-chain 
dehydrogenases, UDP-glucuronosyl or glycosyl transferases, and glutathione-S-
transferases (Lindblom and Dodd, 2006). In order to enhance the sensitivity of the 
worm screening system and to minimize the effective concentration of test compounds 
needed for bioactivity assays, the detoxification response in C. elegans was impeded by 
knocking down a gene encoding a nuclear hormone receptor which is involved in 
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xenobiotic resistance response, nhr-8. Although nhr-8 RNAi worm had been used to 
investigate its sensitivity to toxic compounds that act as nematicide, there is no report 
on studies done to explore nhr-8 RNAi worms’ response to the bioactivities of the 
compounds they were treated with. Further analysis of alkaloids accumulation in the 
worms was done to find out if the increased sensitivity to alkaloid treatment could be 
due to higher bioavailability in the worms. In addition, the differences in detoxification 
genes induction between the alkaloid-treated RNAi control and nhr-8 RNAi worms 





Screening of isoquinoline alkaloids for potent lipid metabolism modulator 
 
Metabolic syndrome is becoming more prevalent in our modern society, posing 
health risks such as cardiovascular disease, stroke and diabetes. Extensive studies are 
being done to search for potent lipid-reducing agents as obesity is linked to the risk 
factors of metabolic syndrome. Currently, the drugs used clinically to control metabolic 
disorders are mainly synthetic compounds such as metformin, thiazolidinediones to treat 
insulin resistance in Type-2 diabetic patients, and lovastatin, alpha lipoic acid to treat 
hyperlipidemia. The search for potent lipid-reducing agents among plant natural 
chemicals is gaining more interest. Several natural compounds have been identified as 
good candidates such as catechin found in green tea (Lee et al., 2009), capsaisin in chilli 
pepper (Iwasaki et al., 2011), and resveratrol in grape seeds and peanut roots (Ahn et al., 
2008). 
In this study, the effects of several isoquinoline alkaloids (Fig. 0-1) on lipid 
accumulation were examined using a vital dye, Nile Red, which stains lipid droplets in 
C. elegans. Nile Red has been widely adopted in C. elegans experiments (McKay et al, 
2003; Ashrafi et al., 2003; Lemieux et al., 2011). However, recent studies reported that 
Oil Red O stain is a more accurate proxy for major fat stores in the subcellular 
compartments of the worm (O’ Rourke et al., 2009). Thus Oil Red O was used to 
validate changes in lipid storage for chemical treatment that showed lipid reduction 
effect after the preliminary screening of chemicals with Nile Red staining. 
Berberine, a benzylisoquinoline alkaloid obtained from Berberis (Berberidaccae) 
and Coptis rhizomes has been in use traditionally for intestinal infection based on its 
antibacterial property. Recently, investigation on its effect on metabolic syndromes such 
as obesity and diabetes are increasing. Since effects such as decrease in plasma 
cholesterol and triglycerides in hypercholesterolemic patients, reduced body weight and 
plasma triglycerides and improved insulin action in high-fat-fed rats have been reported, 
it was suggested as a new cholesterol-lowering drug (Kong et al, 2004). Those 
bioactivities of berberine were reported to be associated with the activation of AMP-
activated protein kinase (AMPK) via the modulation of downstream molecules (Lee et 
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al., 2006; Hwang et al., 2009; Hawley et al., 2010); for instance, the inhibition of ACC 
in HepG2 cells inhibits cholesterol and triglyceride synthesis (Brusq et al., 2006). The 
insulin-sensitizing effect of berberine is reported to have resulted from its activation of 
AMPK which promoted the assembly of high molecular weight (HMW) adiponectin 
and increased the HMW/Total adiponectin ratio in adipocytes (Li et al., 2011). 
Sanguinarine is a benzophenanthridine alkaloid present in the Papaveraceae, 
Fumariaceae, and Rutaceae families of plants and has been reported to exhibit 
antimicrobial, anti-inflammatory and antitumor activities. It is being used as 
antimicrobial component in oral hygiene products and animal feed additive. 
Sanguinarine was recently found to be a direct activator of AMPK (Choi et al., 2011), 
but its application as a lipid modulating agent has not been reported so far. 
AMPK functions like a biological “fuel gauge” (Beale, 2008). It is activated under 
conditions that deplete cellular ATP and elevate AMP levels, such as glucose 
deprivation, heat shock, hypoxia, and ischemia, and also by hormones like leptin, 
adiponectin, catecholamine, and interleukin-6. Recent studies have demonstrated that 
AMPK can also be activated by other stimuli that do not cause a detectable change in 
the AMP/ATP ratio, like hyperosmotic stress and pharmacological agents like 
thiazolidinediones (TZD), metformin, and AICAR. Upon activation, AMPK 
phosphorylates and inactivates a number of metabolic enzymes involved in ATP-
consuming pathways including acetyl CoA carboxylase (ACC), fatty acid synthase, 3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, mammalian target of rapamycin 
(mTOR), and activates ATP-generating process like fatty acid oxidation and glucose 
uptake (Fig. 0-2). AMPK signaling is thus considered a prime target for new therapies 
for metabolic disorders such as insulin resistance and type 2 diabetes (Hardie, 2011). 
Here, the effects of berberine and sanguinarine on lipid reduction through the lipid 
synthesis and fatty acid oxidation via NHR-49, a key regulator of fat consumption in C. 













Materials and Methods 
 
Chemicals and Reagents 
Berberine sulfate was purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, 
Japan); AICAR from Wako Pure Chemicals (Osaka, Japan); sanguinarine chloride, -
Figure 0-2 Scheme showing the effects of AMPK activation on the lipid metabolism 
pathway. 
 
When AMPK is activated, it phosphorylates and inactivates several metabolic 
enzymes involved in ATP-consuming pathways such as acetyl-CoA carboxylase 
(ACC), fatty acid synthase, and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase. The inhibition of ACC leads to the decreased conversion of acetyl-CoA to 
malonyl-CoA, which subsequently activates carnitine palmitoyl transferase (CPT). 
CPT transports long-chain acyl-CoAs into the mitochondrial matrix for -oxidation, 
which eventually enters the citric acid cycle and generates ATP molecules. 
 
The C. elegans genes included in this study are shown in blue italics. aak-1 and 
aak-2 are homologs of the catalytic -subunits of AMPK in the worm. nhr-49 
encodes a C. elegans nuclear hormone receptor which serves as a key regulator of fat 
consumption by targeting several enzymes that are  involved in mitochondrial -
oxidation, including ech-1, acs-2, and cpt-5. 
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lipoic acid and cholesterol from Sigma-Aldrich (St. Louis, MO, U.S.A.); and 
magnoflorine, aromoline, tetrandrine, and isotetrandrine were kind gifts from Dr. K. 
Iwasa (Kobe Pharmaceutical University). Phospho-Thr172-AMPK, AMPK, phospho-
Ser79-ACC and ACC antibodies were from Cell Signaling Technology (Beverly, MA, 
U.S.A.) and horseradish peroxide (HRP)-conjugated donkey anti-rabbit IgG from GE 
Healthcare (Buckinghamshire, U.K.). All other reagents were purchased from Wako 
Pure Chemicals unless otherwise stated. 
 
Nematode Strains 
Wild-type: N2 (Bristol) were maintained on nematode growth media (NGM) at 
20C according to standard culture methods (Stiernagle, 2006). 
 
Nematode Treatment 
In the preliminary screen using Nile Red staining, 3-day-old worms were used. 
When larger amount of worms were required for Oil Red staining, protein and RNA 
extraction, 2-day-old worms were used for treatment in subsequent assays to avoid a 
mixed population of adult worms, eggs, and larval L1 at the end of 24h treatment. 
 
Nile Red Staining 
Synchronized 3-day-old C. elegans were treated with various chemicals for 24 hours 
on NGM medium plated with E. coli OP50 as a food source, 50 ng ml
-1
 Nile Red 
(Sigma Chemicals) and test compounds at the indicated final concentrations. Ten to 12 
worms were treated in duplicate for each test compound in three independent 
experiments. After 24 hours of culture at 20C, 10 to 12 worms were randomly selected 
for observation under bright field, and red fluorescence images were obtained using a 
Keyence BIOREVO BZ-9000 Imaging System (Keyence Corporation, Osaka, Japan). 
Hazy images were omitted and the rest were used to quantify the fluorescence intensity 
of lipid droplets using ImageJ software (http://rsbweb.nih.gov/ij/). The results were 
verified by reproducibility in at least two of three independent experiments. The figures 




Oil Red O Staining 
Two-day-old worms were treated with and without alkaloids (as a control) for 24 
hours as in the Nile Red staining experiments. About 200-300 worms were collected 
and washed three times with 1X PBS pH 7.4 buffer.  Oil Red O staining was performed 
as previously reported by O’ Rourke et al. (2009). After staining, 10 to 12 worms were 
randomly selected for observation under bright field, and images were captured using a 
Keyence BIOREVO BZ-9000 Imaging System. Hazy images were omitted and the rest 
were used to quantify the intensity of Oil Red O staining using ImageJ software. Each 
color image was separated into its RGB channel components and the green channel was 
used for further analysis following previous method by Yen et al. (2010). The results 
were verified by reproducibility in at least two of three independent experiments. The 
figures represent the results from one experiment. 
 
RNA Interference 
An RNAi feeding method (Lehner et al., 2006) was used. Part of the nucleotides of 
the coding regions of aak-1, aak-2, and nhr-49 complementary DNA were used for 
RNAi. The following primers were used: 
aak-1 forward, 5'-ATGCCTCCAAGTGGACGTTTCGATA-3'; aak-1 reverse, 5'-
CAGCAAGTAGAGCTCCAGTTACATC-3'; 
aak-2 forward, 5'-ATGTTTTCTCATCAAGATCGAGACCG -3'; aak-2 reverse, 5'-
TACAACTTTCCGCTAATAACCTCAGG-3'; 
nhr-49 forward, 5'-ATGGACCTAGTAGATCCTCTTG-3'; nhr-49 reverse, 5'-
AGAGGATGAATTGCCAATGGAG-3'. 
Primers were fused with restriction enzyme sites: Xba1, Xho1 for aak-1 and aak-2; 
Xba1, Xma1 for nhr-49 and were used to amplify the genes of interest. Each cDNA 
segment was cloned into feeding vector pL4440 (A. Fire, Stanford University, CA, 
U.S.A.) with respective restriction sites and transformed into HT115 bacterial cells. 
Colonies were screened and positive transformants were confirmed by PCR using the 
original primer pairs. RNAi control worms were fed bacteria carrying an empty pL4440 
vector. 
HT115 bacteria containing an RNAi vector or control vector were grown in Luria-
Bertani (LB) broth with 25 g ml-1 carbenicillin overnight at 37C, and induced with 1 
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mM isopropyl--D-thiogalactopyranoside (IPTG) for the final 3 hours. The bacterial 
culture was pelleted and resuspended in the same volume of S-medium with added 1 
mM IPTG and 25 g ml-1 carbenicillin, and 500 l was dispensed into each well of a 
24-well plate. Two synchronized L3 larval worms were added to each well. Plates were 
incubated at 20C for 3 days, during which period the worms would have laid eggs that 
then hatched and grew to the L3 larval stage. 2-day-old worms were treated with the test 
compounds in 500 l of S-medium with fresh HT115 RNAi bacteria culture, 1 mM 
IPTG and 25 g ml-1 carbenicillin per well. The plates were incubated at 20C for 24 
hours and RNAi worms that had been treated with the same test compound were 
combined (24-wells). Worms were washed in M9 1X buffer and subjected to the 
measurement of Oil Red O staining intensity, or protein or RNA extraction. 
 
Quantitative RT–PCR 
Total RNA was extracted with Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, 
Japan), purified with an RNeasy Mini Kit (Qiagen, Hilden, Germany), and reverse-
transcribed into cDNA using SuperScript III reverse transcriptase (Invitrogen, Carlsbad, 
CA, U.S.A.) with oligo(dT) primer. cDNA (final concentration of 500 pg l-1) was 
subjected to qRT-PCR analysis using the CFX96 Real-Time PCR System (Bio-Rad 
Laboratories, Inc., Foster City, CA, U.S.A.) with IQ SYBR Green Super Mix (Bio-Rad, 
Hercules, CA, U.S.A.). The conditions for PCR reactions were 95C for 15 min, 
followed by 40 cycles of 95C for 10s, 60C for 20s and 72C for 20s. Melting curve 
analysis was performed after each run at 72C to 95C to check the specificity of 
amplification. Data were analyzed using Bio-Rad CFX Manager (Bio-Rad) Version 1.5.  
The number of transcripts in a sample was determined by comparing the number of 
cycles (c) required for the reaction to reach a common threshold (t). The relative amount 
of transcript between samples was further standardized by the amplification of cdc-42 as 
an internal control. 
Sequences of forward and reverse primers used in quantitative RT-PCR analysis: 




acs-2 forward, 5'-TGACGTGCTCAAGTCTCCAC-3'; acs-2 reverse, 5'-
CTTCACCATCTTCTCGCACA-3'; 
cpt-5 forward, 5'-TGCGATGGAGCTGAGTTAGA-3'; cpt-5 reverse, 5'-
GTGACAGTCGCAATCTCCAA-3'; 




Two-day-old C. elegans were treated with 1 mM of various chemicals for 24 hours 
on NGM medium plated with E. coli OP50 as a food source. The nematodes were 
collected and washed with M9 1X buffer. After M9 buffer was removed, 50 l of 
nematode sample was dispensed into Eppendorf tubes, protease inhibitor cocktail 
(Calbiochem, Billerica, MA, U.S.A.) was added, and protein was extracted with 1X 
Sample buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 6% 2-mercaptoethanol, 10% glycerol, 
0.01% bromophenol blue, distilled water). Protein concentrations were determined by 
the Bradford method and, for each sample, 20 g protein was loaded and separated by 
SDS-PAGE. Proteins were electro-transferred onto a polyvinylidene difluoride 
membrane (PVDF) (Millipore Immobilon-P, Billerica, MA, U.S.A.) and probed with 
phospho-Thr172-AMPK  or phospho-Ser79-ACC [1/2000x dilution in 5% BSA/Tris 
buffered saline with Tween-20 (TBST)], followed by HRP-conjugated secondary 
donkey anti-rabbit IgG (1/5000x dilution in 5%BSA/TBST) and chemiluminescence 
was detected using ImageQuant LAS4010 (GE Healthcare Life Sciences, 
Buckinghamshire, U.K.). Blots were then stripped and reprobed with AMPK or ACC 
(1/2000x dilution in 5%BSA/TBST) and subjected to chemiluminescence detection. 
 
Results and Discussion 
 
Identification of alkaloids that affect lipid accumulation in worm using Nile Red and 
Oil Red O stain 
 
C. elegans were treated with isoquinoline alkaloids such as berberine 
(protoberberine-type), sanguinarine (benzophenanthridine-type), magnoflorine 
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(aporphine-type), aromoline, tetrandine, and isotetrandine (bisbenzylisoquinoline-type) 
in the presence of Nile Red for 24 hours. 5-Aminoimidazole-4-carboxamide ribotide 
(AICAR) and alpha lipoic acid were selected as reference of lipid reducing agents (Fig. 
0-1). AICAR, a nucleoside converted within cell to an AMP mimetic, is commonly used 
as AMPK activator which affects lipid metabolism resulting in lipid reduction (Fryer et 
al., 2002; Lee et al., 2006; Hawley et al., 2010). Alpha lipoic acid has known 
pharmacological effect to improve hypertriglyceridemia by stimulating triacylglycerol 
clearance and down-regulating liver triacylglycerol secretion. 
After 24 hours, AICAR, berberine and sanguinarine treated worms showed marked 
reduction of lipid accumulation as reflected in weaker fluorescence intensity compared 
to untreated worms (Fig. 1-1A, B), whereas other alkaloids showed little or no reduction 
of fluorescence up to 5 mM concentration. At 1 mM concentration, alpha lipoic acid 
showed weak reduction of lipid. It is noted that with 24-hour treatment in this 
experiment set-up, no abnormality in the worms` growth or mobility associated with the 









Fig. 1-1(A) Nile Red staining in treated worms. Berberine, sanguinarine, AICAR, and 
alpha lipoic acid were treated at 1 mM. Magnoflorine, isotetrandrine, tetrandrine, and 
aromoline were treated at 5 mM concentration. Images show typical results in worms 
treated with each test compound for 24 hours. Magnification is at 40 for top row and 
20 for bottom row (Scale bar = 100 m); exposure time = 1/25 s; light intensity = 
40%. 
Fig. 1-1(B) Quantification of Nile Red fluorescence intensity in treated worms using 
ImageJ software; average values are shown for each compound tested and normalized 
to the control sample. n = 10 each from 3 independent experiments, error bars = SD. 
*p < 0.05 (ANOVA followed by Dunnett`s test). 
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The lipid reduction effects of berberine and sanguinarine were verified using Oil 
Red O stain (Fig. 1-1C, D). Among the non-effective compounds tested with Nile Red 
stain, only magnoflorine and tetrandrine were confirmed using Oil Red O stain due to 
limited availability of chemicals (Fig. 1-1 E, F). 
 
(C)            (D) 
 
 






Fig. 1-1(C) Oil Red O staining in treated worms. Images show typical results in 
worms treated with berberine or sanguinarine for 24 hours. Magnification at 10 
(Scale bar = 100 m). (D) Quantification of Oil Red O staining intensity in treated 
worms using ImageJ; average values are shown for each compound tested and 
normalized to the control sample, error bars = SD. *p < 0.05 (ANOVA followed by 
Dunnett`s test). 
Fig. 1-1(E) Oil Red O staining in treated worms. Images show representative results 
in worms after treatment with magnoflorine or tetrandrine for 24 hours. 
Magnification at 20x (scale bar = 100 m). n = 10-12 each from 3 independent 
experiments. (F) Quantification of the intensity of Oil Red O staining in treated 
worms using ImageJ. Values are the average of 10-12 images for each compound 
tested and are normalized to the control sample, error bars = SD. 
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The lipid-reducing effects of berberine and sanguinarine were found to be dose-
dependent. Interestingly, sanguinarine exhibited more potent lipid reduction activity 
than berberine. When tested with lower concentration of sanguinarine, 25 M still 
showed significant reduction of lipid accumulation, at almost 20-fold lower than the 
effective concentration of berberine (Fig. 1-2A, B). Further experiments were carried 
out to elucidate the difference in lipid reduction efficacy between berberine and 
sanguinarine based on the postulated pathways they act upon. 
 
(A)          (B) 
 
 
Enhanced phosphorylation of AMPK in berberine- and sanguinarine-treated worms 
 
The involvement of AMPK pathway in berberine-induced fat reduction has been 
reported, whereby the inhibition of ACC in HepG2 cells resulted in the inhibition of 
cholesterol and triglyceride synthesis (Hawley et al., 2010; Brusq et al., 2006). Here, the 
effect of sanguinarine on AMPK and its downstream substrate, ACC, was further 
characterized in comparison with berberine. To examine the activation conditions of 
AMPK and ACC, their phosphorylation conditions were checked using anti-phospho 
AMPK (pAMPK)- and anti-phospho ACC (pACC)-specific antibodies. Sanguinarine 
and AICAR treatment for 24 h induced phosphorylation of AMPK but phosphorylation 
of ACC was insignificant. Meanwhile, berberine had only a marginal effect on AMPK 
Fig. 1-2 Oil Red O staining in worms treated with (A) berberine and (B) sanguinarine 
for 24 hours. Magnification at 20x (scale bar = 100 m).  n = 10-12 each from 3 
independent experiments, error bars = SD. *p < 0.05 (ANOVA followed by 
Dunnett`s test). C is control. 
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and ACC (Fig. 1-3A, B). Transient AMPK activation could be a possible reason for the 
weak phosphorylation detected. For instance, experiments using AICAR to activate 
AMPK had been reported whereby maximum phosphorylation activity was observed at 
60 min (Pang et al., 2010) and at 2 h (Anilkumar et al., 2013) after which it gradually 
reduced to base level. Han et al. (2010) reported that berberine increased 
phosphorylation of AMPK and ACC in a dose- and time-dependent manner which 
peaked at 60 min after addition of 10 M berberine to bovine aortic endothelial cells. 
Since lipid reducing effect in worms using staining method was observed after 24 h 
alkaloid treatment, protein samples from 24 h-treated worms were used in earlier 
experiments. As follow-up, worms were treated with 500 M berberine for 12 h and 
checked for AMPK and ACC activation conditions. Although statistically insignificant, 
increased AMPK phosphorylation was obvious when compared to 24 h treated worms 
(Fig. 1-3C, D). These results imply that there is a time lag between the peak of AMPK 
activation and the observable lipid-reducing effect. Therefore, time-course experiment 





(A)     (B) 
 
 





Fig. 1-3 Immunoblot showing phosphorylation of AMPK and ACC in treated worms. 
(A) Representative immunoblots of worm protein extracts for anti-phospho AMPK 
(pAMPK), anti-AMPK (AMPK), anti-phospho ACC (pACC) and anti-ACC 
(ACC) and (B) average phosphorylation levels of AMPK and ACC in worms treated 
for 24 h from three independent experiments. (C) Representative immunoblots and 
(D) average phosphorylation levels of AMPK and ACC in worms treated for 12 h 
from two independent experiments. Band intensities were quantified using ImageJ 
and normalized to total AMPK or ACC levels in control worms, error bars = SEM.  
*p < 0.05 (ANOVA followed by Dunnett’s test). 
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Knockdown of the C. elegans homologs of catalytic -subunits of AMPK revealed 
involvement of aak-2 in the lipid modulation mechanisms for berberine and 
sanguinarine 
 
To investigate the mechanism through which AMPK activation might have induced 
lipid reduction in treated worms, the genes encoding the two C. elegans homologs of 
the catalytic -subunits of AMPK, aak-1 and aak-2 were knocked down.  AAK-1 and 
AAK-2 are 40% and 52% identical to, and they share 71% and 80% amino acid identity 
respectively with the kinase domain of the human AMPKα subunits, including 
conservation of a critical threonine residue whose phosphorylation is required for 
AMPK activation (Apfeld et al., 2004). The function of AAK-1 was much 
uncharacterized until a recent study by Lemieux et al. (2011) through which they 
identified an undisclosed compound F17 that activated AMPK signaling in C. elegans 
via aak-1. 
Although phosphorylation of AMPK was observed, further RNAi experiments 
showed that lipid reduction activity of berberine and sanguinarine was still effective in 










Although less viable compared to wild-type worms, aak-1(tm1944) mutants was 
reported to survive better than aak-2(ok524) mutants during larval L1 diapause 
(Fukuyama et al., 2012). It suggests that aak-2 has a more critical function in promoting 
survival under nutritional stress condition. According to the findings of Li et al. (2006), 
the 1 and 2 isoforms of the catalytic AMPK subunits are present in most tissues but 
are differentially activated. Salt et al. (1998) reported that the α1-isoform was less 
activated than the α2-isoform in the rat’s heart and skeletal muscle suggesting the lower 
sensitivity of the α1- than the α2-isoform complexes to smaller increases in AMP 
concentration. 
In this study, quantitative real-time PCR analysis of the transcripts level of aak-1 
and aak-2 in aak-1 RNAi worms showed that aak-2 expression was induced to a ratio 
comparable to the reduction of aak-1 whereas the aak-1 expression level was unaffected 
in aak-2 RNAi worms (Fig. 1-5A, B). This result suggests that the worms’ AMPK -
subunit expressions are regulated mainly through aak-2 to maintain endogenous AMPK 
Fig. 1-4 Knockdown of the C. elegans homologs of catalytic -subunits of AMPK 
revealed that aak-2 was involved in the mechanisms of lipid-modulation for berberine 
and sanguinarine. The relative intensity of Oil Red O-stained lipid droplets quantified 
using ImageJ in (A) aak-1 and (B) aak-2 RNAi worms treated for 24 hours with 
berberine, B at 200 M or 400 M and sanguinarine, S at 25 M. n = 10-12 for each 
compound tested; error bars = SD; *p < 0.05 (ANOVA followed by Dunnett`s test). 




level and it accounts for most of the basal activity and activation by berberine and 
sanguinarine. It also implies that, in this worm, the aak-1 isoform of the AMPK α- 
subunit is less responsive to activation by berberine and sanguinarine. 
 




Lipid- reducing effects of berberine and sanguinarine are independent of the nhr-49 
regulated fatty-acid beta-oxidation pathway 
 
Nuclear receptors (NRs) are a diverse class of transcription factors that mediate 
hormonal signaling processes in vertebrates and insects and now known to extend 
beyond direct transduction of endocrine signals to include responses to a variety of 
signaling molecules, participation in multiple signal transduction pathways, and 
regulation of diverse physiological and developmental processes. While many of the 
mechanisms by which ligand-regulated, hormone-responsive NRs activate or repress the 
transcription of target genes have been well characterized, the remaining orphan NRs 
lack known cognate ligands (Gissendanner et al., 2004). The C. elegans genome 
sequence contains 284 confirmed or predicted NR genes which is over 5-fold more than 
Fig. 1-5 Quantitative RT-PCR of aak-1 and aak-2 transcript levels in (A) aak-1 and 
(B) aak-2 RNAi worms. mRNA abundance values represent the average of triplicate 
cDNA templates applied to run qRT-PCR and the results were normalized against 
cdc-42 as an internal control. Results were verified by reproducibility in at least two 
of three independent experiments and representative results from one experiment are 
shown, error bars = SD. *p < 0.05, **p < 0.005, two-tailed t-test. pL4440 – RNAi 
vector control, aak-1i – aak-1 RNAi worms, aak-2i – aak-2 RNAi worms. 
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the number found in the human genome (Maglich et al., 2001), with a few of them 
exhibiting conserved physiological functions across taxa. 
The C. elegans nuclear hormone receptor gene nhr-49 has significant homology 
with hepatocyte nuclear factor 4 (HNF4) in mammals but its function is closer to the 
mammalian peroxisome proliferator-activated receptors (PPARs). nhr-49 serves as a 
key regulator of fat usage by modulating fat consumption pathways and maintaining 
fatty acid saturation in balance. It targets multiple enzymes involved in transporting 
fatty acids across the mitochondrial membrane for -oxidation. nhr-49 knockout 
exhibited high-fat phenotype that was attributed to the deficiencies in two metabolic 
pathways, fatty acid -oxidation and fatty acid desaturation. nhr-49 was found to 
stimulate expression of a carnitine palmitoyl transferase (F09F3.9) which acts 
downstream of acyl-CoA synthetase in shuttling activated acyl-CoAs into the 
mitochondrial matrix (Van Gilst et al., 2005). 
The involvement of -oxidation genes targeted by NHR-49 in lipid reducing effects 
of berberine and sanguinarine was investigated through RNAi experiments. As 
mitochondrial -oxidation process degrades stored fats for the production of energy, 
reduced expression of the key -oxidation enzymes would result in high-fat storage. 
Consistent with the reported high-fat phenotype, nhr-49 RNAi worms were found to be 
slightly larger in size and had increased fat storage with Oil Red O stain (Fig. 1-6A, B). 
They also had significantly lower expressions of mitochondrial -oxidation genes, i.e., 
ech-1 (encodes a mitochondrial -oxidation trifunctional enzyme), cpt-5 (encodes a 
carnitine palmitoyl transferase), and acs-2 (encodes a mitochondrial acyl-CoA 











Fig. 1-6 Effects of alkaloid treatment on nhr-49 RNAi worms. (A) Relative intensity 
of Oil Red O-stained lipid droplets quantified using ImageJ in nhr-49 RNAi worms 
treated with berberine, B (400 M) or sanguinarine, S (25 M) for 24 hours. C is 
non-treated control; n = 10-12 for each compound tested, error bars = SD. *p < 0.05 
(ANOVA followed by Dunnett`s test). (B) Oil Red O staining of RNAi control worm 
and nhr-49 RNAi worms. Images show typical results with worms at 20 
magnification (Scale bar = 100 m). 
Fig. 1-7 Quantitative RT-PCR analysis on the expression of fatty-acid oxidation 
genes. The mRNA abundance value represents the average of triplicate cDNA 
template applied to run qRT-PCR and the results were normalized against cdc-42, 
error bars = SD. *p < 0.05 (ANOVA followed by Dunnett`s test). pL4440 – RNAi 
vector control, nhr-49i – nhr-49 RNAi worm. Results were verified by 
reproducibility in at least two of three independent experiments. 
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Despite their high fat accumulation, nhr-49 RNAi worms still retained sensitivity to 
berberine and sanguinarine (Fig. 1-6A), suggesting that both alkaloids act independently 
of nhr-49 and their fat reducing activity would be on fat biosynthesis rather than its 
catabolism. However, analysis of nhr-49 transcript level in RNAi control worms treated 
with berberine and sanguinarine showed reduced nhr-49 expression (Fig. 1-8). These 
results suggest that they have antagonistic action on the lipid synthesis and degradation 
processes. While the details of the antagonistic action of berberine and sanguinarine on 
lipid synthesis (via AMPK) and degradation (via NHR-49) remains to be elucidated, the 







Fig. 1-8 Quantitative RT-PCR analysis on the expression of nhr-49 gene. The mRNA 
abundance value represents the average of triplicate cDNA template applied to run 
qRT-PCR and the results were normalized against cdc-42, error bars = SD. *p < 0.05 
(ANOVA followed by Dunnett`s test). pL4440 – RNAi vector control, nhr-49i – nhr-





Application of the whole-worm model to screen for lipid reducing activities of 
metabolically-engineered plant cell cultures 
 
Although many of the phytochemicals exhibit therapeutic effects, a lot of them still 
cannot be synthesized efficiently in the laboratory. One possible way to enhance 
production involves combination of biochemical knowledge, cloning, and 
transformation techniques, such as increasing the supply of bioactive compounds 
through metabolic engineering. The identification of many biosynthetic genes and 
characterization of the spatial and developmental regulation of their expression had 
proven their importance in the biosynthesis of secondary metabolites and revealed 
bottlenecks for their production in plant cells. Metabolic engineering of plant secondary 
metabolites biosynthesis pathway could improve quality of metabolites by reducing 
undesired pathways, introducing new pathways to produce novel compounds, or by 
completely blocking a pathway to accumulate intermediates (Chow and Sato, 2013). In 
the metabolic engineering of alkaloids, isoquinoline alkaloid biosynthesis has been most 
intensively investigated for production of bioactive compounds with pharmaceutical 
values. 
Eschscholzia californica (California poppy) accumulates pharmacologically active 
alkaloids biosynthetically related to the morphinan alkaloids of Papaver somniferum. 
This, in combination with the relative ease with which it is propagated in vitro, makes it 
a key model for benzylisoquinoline biosynthesis (Loyola-Vargas and Vázquez-Flota, 
2006). In this study, transgenic cell lines produced by heterologous expression of 
CYP80G2, a cytochrome P450 gene, from Coptis japonica in E. californica cells were 
screened for lipid-reducing effect in comparison with wild-type and vector control E. 
californica cell cultures. In addition, effect of C. japonica cell culture extract which 






Materials and Methods 
 
Chemicals and reagents 
Sanguinarine (Sigma), magnoflorine (a gift from R. Nishida, Kyoto University), and 
scoulerine ( a gift from Mitsui Chemicals, Inc., Japan), berberine sulfate (Tokyo 
Chemical Industry Co., Ltd.), palmatine chloride (Mitsui Petrochemical Industries), 
coptisine chloride (Wako Pure Chemicals, Osaka, Japan), columbamine (prepared in our 
laboratory; Ikezawa et al.,2007). All other reagents were purchased from Wako Pure 
Chemicals unless otherwise stated. 
 
Plant cell cultures 
Wild-type, vector control and transgenic CYP80G2-overexpression E. californica 
cell lines were established and are maintained by our laboratory. The integration of the 
CYP80G2 expression construct in transgenic cells was confirmed by genomic PCR. 
Expression level of CYP80G2 in those transgenic cells was further validated by qRT-
PCR. The C. japonica (156-S) cell line was established by Sato et al. (2001) and is 
maintained in our laboratory. 
Fig. 2-0 Partial schematic of the isoquinoline biosynthesis pathway  
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LC-MS analysis of metabolites in E. californica cultured cells extracts 
Constantly growing wild-type, vector control and transgenic CYP80G2 
overexpression cells were used for the alkaloid analysis. Cultured cells were harvested 
after 14 d of culture and alkaloids were extracted from 2.0 g of fresh weight cells with 8 
ml of methanol for 24 h. After homogenization and centrifugation, the alkaloids in 
supernatants were concentrated using rotary evaporator. The extracts were dissolved in 
distilled water and used for bioassay. The contents were determined by LC-MS 2010 
(Shimadzu) with isocratic 40% (v/v) acetonitrile/H2O solvent containing 0.05% (v/v) 
trifluoroacetic acid (TFA) at constant flow rate of 0.8 ml/min. Column = TOSOH TSK-
Gel ODS 80-Tm silica-based, reversed phase 4.6 x 250 mm; column temperature = 
40C. UV absorbance was measured at 280 nm; mass range (m/z 100 to 800) by both 
single-ion and scan modes. Sanguinarine, magnoflorine, and scoulerine were identified 
by direct comparison with standard chemicals in LC-MS analysis. Identification of 
other main peaks was deduced from their m/z values based on previous study 
(Takemura et al., 2010). Alkaloids concentrations were quantified relative to the peak 
area of standards. 
 
LC-MS analysis of metabolites in C. japonica cultured cells extracts 
10.0 g of fresh weight C. japonica (156-S) cells were soaked in 100 ml methanol for 
48 h. The filtered extract was concentrated using rotary evaporator and dissolved in 
distilled water for bioassay and analysis by LC-MS 2010 (Shimadzu). 
H2O(A)/acetonitrile (B) solvent containing 0.05% (v/v) TFA was used at constant flow 
rate of 0.5 ml/min. After initial hold at 35% B for 15 min, linear gradient was applied 
from 35% to 70% B in 4 min, hold at 70% B for 3 min, 70% to 35% B in 4 min and 
finally hold at 35% B for 4 min. Column type, column temperature and detection 
parameters were same as above. Peaks were identified by direct comparison with 
standard chemicals and alkaloids concentrations were quantified relative to the peak 
area of standards. 
 
C. elegans bioassay 
Two-day-old worms were treated with distilled water (as control), cell extracts, or 
alkaloids for 24 hours. About 200-300 worms were collected and washed three times 
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with 1X PBS pH 7.4 buffer. Oil Red O staining and its quantification were performed as 
described in Chapter I. 
 
Results and Discussion 
 
Alkaloid profiles of E. californica cultured cells extracts 
 
Since CYP80G2 has been identified as corytuberine synthase (Ikezawa et al., 2008) 
acting on substrate, (S)-reticuline, this infers that heterologous expression of CYP80G2 
gene from C. japonica in E. californica cells may alter its alkaloid biosynthesis pathway 
to branch off at (S)-reticuline and produce (S)-corytuberine and/or magnoflorine as 
intermediate or end-products. It could also concurrently assume its inherent pathway to 
produce (S)-scoulerine, sanguinarine, or accumulate other intermediates (Fig. 2-0). 
LC-MS analysis of the cell extracts (Fig. 2-1) revealed similar alkaloids 
composition in wild-type (W), vector control (G) and CYP80G2-overexpression (C) 
culture cells. The main peaks identified based on known m/z values are magnoflorine 
(m/z 342), scoulerine (m/z 328), sanguinarine (m/z 332), protopine (m/z 354), 
allocryptopine (m/z 370), 10-hydroxychelerythrine (m/z 364), chelerythrine (m/z 348), 
chelirubine (m/z 362). The CYP80G2-overexpression culture cell lines have similar or 
higher magnoflorine content compared to the wild-type or vector control lines. However, 
accumulation of scoulerine and sanguinarine were also found. It is noted that line C9 
had remarkably higher alkaloid content compared to other transgenic cell lines with the 









Fig. 2-1 Liquid chromatogram of wild-type (W), vector control (G) and CYP80G2-
overexpression (C) E. californica cell extracts. Labeled peaks indicate m/z 342 
(magnoflorine), m/z 328 (scoulerine), m/z 332 (sanguinarine ), m/z 354 (protopine), 
m/z 370 (allocryptopine), m/z 364 (10-hydroxychelerythrine),  m/z 348 





Fig. 2-2 (A) Total concentration of three alkaloids and the respective concentration 
for  (B) magnoflorine (m/z 342), (C) scoulerine (m/z 328) and (D) sanguinarine (m/z 
332) in E. californica cell extracts. Semi-quantitative values are presented here as M 




Lipid-reducing effect of E. californica cell extracts in C. elegans 
 
Extracts from wild-type (W), vector control (G) and CYP80G2-overexpression (C) 
culture cells with the alkaloids profile and concentration shown in Fig. 2-1 and 2-2 were 
fed to the worms for 24 h and effects on lipid accumulation was observed using Oil Red 
O stain. Among the extracts from 10 culture cell lines tested, only C9 showed 
significant lipid reduction in worms (Fig. 2-3). One obvious factor for the effectiveness 
of C9 is its high alkaloids content (244 M magnoflorine, 85 M scoulerine and 191 
M sanguinarine) compared to other cell line extracts (Fig. 2-2A). By comparison of the 
alkaloids composition of various cell line extracts, the profile of G9 resembles that of 
C9 with similar concentration of scoulerine (80 M) and high sanguinarine(72 M) 
content. Although G9 contained only 22 M magnoflorine, it is known from earlier 
results that magnoflorine did not have lipid-reducing effect in the worms (Chapter I, Fig. 
1-1F). This ruled out the contribution of magnoflorine in the lipid-reducing effect in 
treated worms. Since both lines contained similar amount of scoulerine at 85 M (C9) 
and 80 M (G9) but G9 extract did not have significant lipid-reducing effect in treated 
worms, it showed that scoulerine was ineffective at lipid-reduction at those 
concentrations. Moreover, C1 extract, with relatively high content of magnoflorine (135 
M) and scoulerine (38 M) but low content of sanguinarine (2 M) as compared to C9, 
did not reduce lipid accumulation in the worms. These results suggest that sanguinarine 
is the main contributor to the lipid-reduction activity observed with C9 extract. 
Although the effective concentration of sanguinarine was not determined here, it 
was noted that its lipid-reducing effect was weaker in the presence of other metabolites 
contained in plant cell culture extracts. For example, G9 which contained 72 M 
sanguinarine did not yield lipid-reducing effect whereas 25 M sanguinarine was 







Lipid-reducing effect of C. japonica cell extracts in C. elegans 
 
The lipid-reducing effect of berberine was confirmed using the C. elegans screening 
model although its activity was lower than sanguinarine (Chapter I). Several medicinal 
plants such as Coptis contain berberine. Thus, I examined the effect of the extracts from 
high berberine-producing 156S cells of C. japonica on lipid reduction of the worm. LC-
MS analysis indicated that C. japonica 156S cell extract contained berberine (m/z 336), 
magnoflorine (m/z 342), coptisine (m/z 320), palmatine (m/z 352), and some 





Fig. 2-3 Quantification of Oil Red O staining intensity in treated worms using 
ImageJ; average values are shown for10-12 images of each extract tested and 
normalized to the control sample, error bars = SD. ***p < 0.001 (ANOVA followed 
by Dunnett`s test). 
Fig. 2-4 Liquid chromatogram of C. japonica (156S) cell extract.    
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The C. japonica 156S cell extract was diluted to a final concentration of about 109 
M berberine, 5 M palmatine and 23 M coptisine and applied to the worms as in 
Chapter I. Oil Red O staining of worms after 24 h treatment showed that C. japonica 
cell culture extract had stronger lipid-reducing effect than 100 M berberine applied 




Mixed compositions in extracts of E. californica and in C. japonica cell cultures 
affect lipid-reducing activity differently 
 
Plant extracts with a mixed composition of secondary metabolites are commonly 
applied as traditional therapeutics. The combination of active components is believed to 
produce synergistic effect for treatment of different ailment. The results here showed 
that the C. japonica cell extract have a stronger lipid-reducing effect than berberine 
alone. This implies a synergistic effect between berberine and other components in the 
extract. In fact, some of the protoberberine alkaloids showed similar effects on lipid 
accumulation as berberine (Kawasaki, unpublished results). On the contrary, results 
from treatment with E. californica cell extract suggest other components had an 
antagonistic effect on sanguinarine which is more effective when applied alone. 
Besides the major alkaloids identified here by LC-MS analysis, there are other 
bioactive components present in the cell extracts including phenolic compounds such as 
flavonoids, polyphenols and phenolic acids yet to be analyzed. Phenolic compounds are 
reported to have antioxidant, antimicrobial, and antitumor properties (Guimarães et al., 
Fig. 2-5 Quantification of Oil Red O staining intensity in treated worms using 
ImageJ; average values are shown for10-12 images of each treatment and normalized 
to the control sample, error bars = SD. **p < 0.01, ***p < 0.001, two-tailed t-test. 
B – berberine, CE – cell extract. 
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2013; Wang et al., 2013; Dias et al., 2013) and their presence in crude extracts could 
affect the overall bioactivity. In this study, the results indicate that the interactions 
between protoberberine-type alkaloid and other metabolites in the C. japonica cell 
extracts yield different bioactivity strength than that of the benzophenanthridine-type 
alkaloids found in E. californica cell extract. Results of C9 suggests that its bioactivity 
is more related to the constituents profile than to the amounts present in the extract since 
the effective concentration of sanguinarine was determined earlier to be 25 M. 
It is interesting that the non-alkaloid components might be synergistic in one extract 
and antagonistic in another. While synergism of alkaloids with other plant secondary 
metabolites had been reported (Eid et al., 2012a), antagonistic effects were found in 
other studies. Dias et al. (2013) reported that purified extracts of wild fruits, Arbutus 
unedo, Prunus spinosa, Rosa micrantha and Rosa canina, exhibited higher antioxidant 
properties than the crude extracts in which antagonistic effects between the compounds 
present resulted in a decrease in the antioxidant activity. While further investigations are 
needed to identify and compare the other non-alkaloid chemical constituents between C. 
japonica and E. californica cell cultures and to evaluate their effects on the overall 
bioactivity of extracts, this worm model is useful in the preliminary screening as it 
reflects a more comprehensive response of an organism as a whole compared to in-vitro 
or cell-based assays. Such studies will help elucidate the interaction of bioactive 





RNAi knockdown of nhr-8 enhanced worms’ sensitivity to bioassay 
 
As described in previous chapters, C. elegans is a good model organism for 
isoquinoline alkaloids bioassay. However, this worm is less sensitive to chemicals 
compared to other assay systems such as mammalian cell cultures (Broeks et al., 1995; 
Kong et al., 2004; Burns et al., 2010). Under natural conditions, C. elegans are exposed 
to large range of chemical assaults found in soil. Besides feeding on microbes, it 
behaves like a scavenger in the soil environment, consuming compounds from other 
animals, microorganisms, plants, and xenobiotics. As a result, it requires efficient 
detoxification ability of organic chemicals for survival. Recent studies have identified 
many genes encoding sensors and enzymes that the worms may use in their xenobiotics 
responses such as a large number of four main classes of detoxification enzymes 
including cytochromes P450 (CYP), short-chain dehydrogenases (SDR), UDP-
glucuronosyl or glycosyl transferases (UGT), and glutathione-S-transferases (GST)  
(Lindblom and Dodd, 2006). 
Most studies on C. elegans detoxification mechanism were attempted to circumvent 
its xenobiotic resistance in screening for more effective nematicide candidates among 
compounds that exhibit toxic property, including plant secondary metabolites. nhr-8 is a 
gene which encodes a nuclear hormone receptor involved in  xenobiotic resistance 
response of the C. elegans. Although the actual target genes of nhr-8 have not been 
identified yet, the precedent PXR (pregnane X receptor) and CAR (constitutive 
androstane receptor) activities in vertebrates suggested that NHR-8 may regulate the 
expression of the cytochrome P450 genes in C. elegans. The toxin sensitivity of nhr-8 is 
specific as nhr-8 RNAi worms were found to be more sensitive than wild-type worms to 
the toxins cholchicine and chloroquine but not to the pathogenic bacterium 
Pseudomonas aeruginosa (Lindblom et al., 2001). 
The function of plant alkaloids has been suggested as defense against herbivores and 
pathogens, therefore they are likely to induce xenobiotic response and consequently 
their bioavailability might be reduced in vivo. Accordingly, the isoquinoline alkaloids, 
berberine and sanguinarine, were also expected to induce xenobiotics response in the 
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worms. The genome-wide response of C. elegans to berberine and sanguinarine 
treatment was previously investigated by microarray analysis and the results indicated 
that defense-response and detoxification genes including F08G5.6 (a defense response 
gene), cyp-35C1, gst-5, ugt-21, and ugt-25 were up-regulated (data not shown). 
Although nhr-8 RNAi worm had been used to investigate its sensitivity to toxic 
compounds that act as nematicide, there is no report on studies done to explore nhr-8 
RNAi worms’ response to the bioactivities of the compounds being treated with. In an 
attempt to enhance the sensitivity of the worm screening system and to minimize the 
effective concentration of test compounds needed for bioactivity assays, the 
detoxification response in C. elegans was impeded by knocking down nhr-8 and 
treating the nhr-8 RNAi worms with lower alkaloid concentration to check if this could 
increase the alkaloid bioavailability in those worms. Next, alkaloids accumulation in the 
worms was analyzed to investigate if the increased sensitivity to alkaloid treatment 
could be due to higher bioavailability in the RNAi worms. In addition, the differences in 
detoxification genes induction between the alkaloid-treated RNAi control and nhr-8 
RNAi worms were also analyzed. 
 
Materials and Methods 
 
Chemicals and reagents 
As described in Chapter I. 
 
Nematode treatment 
As described in Chapter I. 
 
Oil Red O staining 
As described in Chapter I. 
 
RNA interference of nhr-8 
An RNAi feeding method (Lehner et al., 2006) was used as described in Chapter I. 




nhr-8 forward, 5'-ATGCCTTCGTCTTCTCCATC-3'; nhr-8 reverse, 5'-
CTCCCCAAATCCACTTTTCA-3' 
nhr-8 primers were fused with Xma1 and Xho1 restriction enzyme sites and were 
used to amplify the genes of interest. Each cDNA segment was cloned into feeding 
vector pL4440 (A. Fire, Stanford University) with respective restriction sites and 
transformed into HT115 bacterial cells. 
 
Quantitative RT–PCR 
To measure the expression levels of xenobiotic response genes, qRT-PCR was done 
as described in Chapter I. The relative amount of transcript between samples was 
standardized by the amplification of cdc-42 as an internal control. 
Sequences of forward and reverse primers used in quantitative RT-PCR analysis: 
cyp-35C1 forward, 5'-AATTGGAGGACATCCTGTCG-3'; cyp-35C1 reverse, 5'-
AAATACAGCTCGGCTCTTGC-3'; 
gst-5 forward, 5'-TCAAGCTCAACGGAAAAACC-3'; gst-5 reverse, 5'-
CCGAAGCCTTCAAGAAGTTG -3'; 
ugt-21 forward, 5'-AGGGAGAAATGCACAAATGC-3'; ugt-21 reverse, 5'-
CTTGCTGCAAATTCCACGTA-3'; 
ugt-25 forward, 5'-AAATCCGAGCCAAATGTCAC-3'; ugt-25 reverse, 5'-
TGCAAGCATATTCGCATTTC-3'; 
F08G5.6 forward, 5'-GTCCCACTGTCACAAGCTCA-3'; F08G5.6 reverse, 5'-
GTTTCGACCGAGAAATCGAG-3'; 
cdc-42 forward, 5'-AGCTTCATTCGAGAATGTCC-3'; cdc-42 reverse, 5'-
CTCGAGCATTCCTGGATCAT-3'. 
 
LC-MS analysis of alkaloids and their metabolites accumulation in worms 
Worms were washed with 0.1% SDS solution and then with M9 buffer to remove 
compounds stuck to the worm cuticle. After washing, worms were homogenized in 2X 
lysis solution (100 mM KCl, 20 mM Tris pH8.3, 0.4% SDS, 120 g/ml proteinase K) 
with coptisine chloride added as internal standard. The lysis samples were incubated 
60C for 1 h and then kept on ice. 100 l cold acetonitrile was added to each lysate, 
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mixed by pipeting, and centrifuged at 800 x g for 5 min. 40 l of sample was injected 
for analysis by LCMS2010 system (Shimadzu) with the following parameters: 
Column = Cosmosil 4.6 x 250 mm 5C18-AR-300; Column temperature = 27C; 
Solvent A = 4.9:95:0.1 (acetonitrile/H2O/TFA);  
Solvent B = 95:4.9:0.1 (acetonitrile/H2O/TFA) using gradient elution as shown below. 
Time (min) Solvent Flow rate (ml/min) 
0.00 15% B 0.7 
0.15 15% B 0.7 
16.75 70% B 0.7 
20.00 100% B 1.0 
23.00 100% B 1.0 
24.00 15% B 0.7 
25.00 15% B - 
UV absorbance was measured at 280 nm; mass range (m/z 100 to 800) by both 
single-ion and scan modes. 
Accumulation of alkaloid and metabolites were calculated based on LC peak area 
relative to the internal standard peak of coptisine. This value is normalized to worm 
protein content in each sample. Protein was extracted with 1X Sample buffer (50 mM 
Tris-HCl pH 6.8, 2% SDS, 6% 2-mercaptoethanol, 10% glycerol, 0.01% bromophenol 
blue, distilled water). Protein concentrations were determined by the Bradford method. 
 
Results and Discussion 
 
RNAi knockdown of nhr-8 enhanced lipid reduction activity of berberine 
 
In previous experiments with wild-type N2 worms (Chapter I), treatment with 500 
M berberine and 25 M sanguinarine consistently yielded detectable lipid reduction 
activity through Oil Red O staining, but lower concentration such as 50 M berberine 
and 10 M sanguinarine were ineffective. In this study, the worms’ detoxification 
process was impeded by knocking down nhr-8 and the effects of alkaloid treatment on 
those worms were examined. Results of nhr-8 RNAi worms showed that 50 M 
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berberine was effective for  lipid reduction at statistically significant level (p < 0.005) 
after 24 hour treatment (Fig. 3-1A), whereas this concentration was ineffective in wild-
type worms. Although lipid reduction effect was also observed at 10 M sanguinarine 
in RNAi control worms, the difference between nhr-8 and the control RNAi worms 
treated with sanguinarine was significant (p < 0.05) (Fig. 3-1B). 
 




In this experiment, I used only berberine (protoberberine-) and sanguinarine 
(benzophenanthridine)-type alkaloids to evaluate the susceptibility of nhr-8 RNAi 
worms to the alkaloids’ lipid-reducing effect. The results showed berberine`s effect was 
more enhanced than sanguinarine’s effect on the nhr-8 RNAi worms. This enhanced 
sensitivity to berberine suggests that detoxification process was induced in the worms 
and may have affected their sensitivity to chemical treatment. Therefore, nhr-8 RNAi 
worms would be useful for future screening experiments to evaluate the full activity of 
test compounds and their sensitivity to detoxification. Moreover, the amount of complex 
plant alkaloids isolated for bioassay could also be reduced. 
 
Fig. 3-1 Effects of (A) berberine and (B) sanguinarine on lipid accumulation in RNAi 
control worm and nhr-8 RNAi worms. Quantification of Oil Red O staining intensity 
using ImageJ. Values are the averages of 10-12 images for each compound tested and 
normalized to the RNAi control sample; error bar = SD; **p < 0.005, ***p < 0.001; 
#
p < 0.05, 
###




Accumulation of alkaloids in nhr-8 RNAi worms at low dosage 
 
Next, to investigate the enhanced sensitivity of nhr-8 RNAi worms to berberine and 
sanguinarine treatment, the accumulation of alkaloids and their metabolites in the 
worms was analyzed to examine whether the bioavailability of alkaloids was modified 
by nhr-8 knockdown. 
In berberine-treated worm samples, four major metabolites of berberine were 
monitored based on the metabolic analyses reported for mammalian cells, i.e., 
berberrubine (m/z 322), thalifendine (m/z 322), demethyleneberberine (m/z 324) and 
jatrorhizine (m/z 338) in rat plasma, human liver microsomes, and in rat and human 
urine (Zuo et al., 2006; Qiu et al., 2008; Li et al., 2011; Ma et al., 2013). 
On the other hand, study on the metabolism of sanguinarine is rather limited. 
Besides dihydrosanguinarine (m/z 334), which was reported as the main metabolite of 
sanguinarine, some metabolites such as m/z 334 after ring cleavage, m/z 320 after 
successive O-demethylation or m/z 336 after ring-cleavage of m/z 334 were also 
detected in human, rat and pig liver microsomes (Deroussent et al., 2010; Zhang et al., 
2013). 
Using these metabolic analyses data for berberine and sanguinarine, the alkaloid 
metabolites in treated worms were analyzed based on the reported m/z values using LC-
MS (Fig. 3-2, 3-3), since standards of those metabolites were unavailable. Preliminary 
experiments using wild-type worms in 6 h and 24 h treatment showed no distinct peak 
difference in metabolite profiles between 6 h and 24 h. The culture media samples also 
showed no difference between 6 h and 24 h. Therefore, in nhr-8 RNAi experiment, 24 h 
worm samples were analyzed. 
In berberine treatment, only accumulation of berberine was detected and no 
molecular ion peak that corresponds to the 4 major metabolites (berberrubine, 
thalifendine, demethyleneberberine and jatrorhizine) nor the glucuronide conjugates 
was found. Thus, the change in berberine content was analyzed in nhr-8 RNAi 
experiment. On the other hand, in sanguinarine treatment, accumulation of sanguinarine 
in the worms was low and two metabolites of sanguinarine (m/z 334, m/z 336) were 











Fig. 3-2 Liquid chromatogram of (A) coptisine (IS), and alkaloids extracted from 
worms, i.e., (B) pL4440 control, (C) nhr-8i control, (D) pL4440 B500 M, (E) nhr-8i 
B500 M, (F) pL4440 B50 M, (G) nhr-8i B50 M, (H) pL4440 S25 M, (I) nhr-8i 
S25 M, (J) pL4440 S10 M, (K) nhr-8i S10 M. 
pL4440 – RNAi vector control, nhr-8i – nhr-8 RNAi worm. IS – internal standard, B 





Although I expected that the nhr-8 RNAi worms would have accumulated more 
alkaloids when the detoxification response was knocked down, such increases in 
alkaloid contents were only detected at low dosages, i.e. 50 M berberine and 10 M 
sanguinarine but not at high dosages, i.e. 500 M berberine (Fig. 3-4A) and 25 M 
sanguinarine (Fig. 3-4B). Since the availability of alkaloids in vivo would be critical for 
biological activity, the increase in alkaloids accumulation in nhr-8 RNAi worms at low 
concentration is an important finding. The genetic analyses of cytoprotective 
mechanisms in C. elegans suggest that such mechanisms may function efficiently at low 
doses but are overwhelmed at high doses (Shore and Ruvkun, 2013). This correlates 
with higher alkaloid retention in the worms at higher dosages in current results (Fig. 3-
4A, B). However, it is unclear why nhr-8 RNAi worms accumulated less alkaloid than 
RNAi control worms at high dosage. As discuss later, there are other orphan receptor 
genes involved in xenobiotic metabolism and nhr-8 knockdown might enhance the other 
detoxification pathways. 
 
Fig. 3-3 Accumulation of berberine, sanguinarine and their metabolites in RNAi 
vector control and nhr-8 RNAi worms. Semi-quantitative values are presented here as 
M quivalence of coptisine, (internal standard used in worm extraction process). 
These values represent the one of three independent experiments. Results were 
verified by reproducibility in at least two of three independent experiments. L4– 
RNAi vector control, N8 – nhr-8 RNAi worm. B – berberine, S – sanguinarine. 
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The major detoxification response genes induced by berberine and sanguinarine are 
mostly NHR-8 independent 
 
Enhanced sensitivity of the nhr-8 RNAi worms to the lipid reduction effects of 
berberine and sanguinarine and higher accumulation of alkaloids in the worms suggest 
that the xenobiotic response in NHR-8 knockdown worms may have been impeded. To 
clarify the actual target of NHR-8, the expressions of the major detoxification genes 
which were up-regulated after berberine and sanguinarine treatment in wild-type worms, 
were analyzed in nhr-8 RNAi worms. However, qRT- PCR analysis showed similar 
increase of gene expression in nhr-8 RNAi worms after berberine and sanguinarine 
treatment as in wild-type worms (Fig. 3-5). 
 
Fig. 3-4 Relative concentration of the accumulation of (A) berberine, (B) 
sanguinarine and their metabolites (m/z 334, 336) in RNAi control and nhr-8 RNAi 
worms. Values are presented relative to the RNAi vector control which was set at 1 
for each concentration tested. These values represent the average of three independent 
experiments. Error bars = SD. L4– RNAi vector control, N8 – nhr-8 RNAi worm, B – 






Differences in induction of xenobiotics response by a wide range of chemicals have 
been found in C. elegans indicating its complexity as well as specificity. Such complex 
response is likely to be regulated by more than a single PXR/CAR-like regulator (NHR-
8). The mediator subunit MDT-15, a transcriptional coregulator in RNA polymerase II 
dependent transcription, appears to regulate a number of nhr-8 independent genes 
encoding cellular metabolic enzymes including CYPs, UGTs and GSTs in response to 
fluoranthene but not -naphthoflavone (Kimura et al, 1997). Taubert et al. (2008) 
reported that the expressions of CYP35C1, gst-5, and ugt-25, among several other 
detoxification genes, are MDT-15 dependent and nhr-8 was dispensable for MDT-15 
Fig. 3-5 Expression of detoxification genes in nhr-8 RNAi worms after alkaloid 
treatment. qRT-PCR showed the expression of. The mRNA abundance value 
represents the average of three independent experiments (each experiment with 
triplicate cDNA template applied to run qRT-PCR and the results were normalized 
against cdc-42). Values are presented relative to the RNAi vector control which was 




dependent expression of those genes. Other transcription factors may also regulate some 
xenobiotic responses such as skn-1, the C. elegans homologue of Cap 'n' Collar 
transcriptional regulator of phase II detoxification and the oxidative stress response 
(Shore and Ruvkun, 2013). 
The qRT-PCR results (Fig. 3-5) also confirmed that the major detoxification genes 
up-regulated after alkaloid treatment were NHR-8-independent. Interestingly, the 
expression level of ugt-21 was reduced in nhr-8 RNAi control, berberine- and 
sanguinarine-treated worms. More detailed studies are needed to determine the target 
genes of NHR-8 although ugt-21 could be one of them. Different sensitivity to 
berberine and sanguinarine treatment in nhr-8 RNAi worms would be useful to 
elucidate the target genes of NHR-8. 
Although the effect of berberine was enhanced in nhr-8 RNAi worms, its effect on 
their mobility and mortality was indistinguishable within 24 hours treatment. Since C. 
elegans has extensive and large number of detoxification genes as shown in Fig. 3-6, 
the effect of NHR-8 knockdown would be marginal on the total detoxification processes. 
Berberine is reported to be substrate of the multidrug membrane transporter, P-
glycoprotein (P-gp) and are readily effluxed, thus resulting in low bioavailability (Wang 
et al., 2009; Maeng et al., 2002). Increase in berberine accumulation (at 50 M) in nhr-8 
RNAi worms suggests that P-gp function may be impeded. On the other hand, 
sanguinarine acts as a P-gp mediated multidrug resistance reversal agent and it inhibits 
ATP-binding cassette (ABC) transporter activity (Eid et al., 2012b), suggesting the 
higher bioavailability and effectiveness of sanguinarine at lower concentration (25 M) 
in comparison with berberine (500 M). More detailed studies of the ABC transporters 
in C. elegans would be useful to elucidate the NHR-8-dependent detoxification process 





One of the advantages in using C. elegans is that about 40% of its genes associated 
with human therapeutical targets have homologs in the worm, making it a good model 
to study drug-target interaction and target validation (Culetto and Sattelle, 2000). Once 
an activity is found, forward and/or reverse genetics can be applied to elucidate the 
possible cellular targets or mechanism of activation. 
In Chapter I, preliminary screening on lipid reduction activity of chemicals in C. 
elegans was carried out by staining method to observe the effects through its transparent 
body wall. The positive results of lipid reduction activities was extrapolated to find out 
if the effect is linked to AMPK signaling pathway as was reported for berberine through 
immunoblotting and gene knockdown experiments. Most of the reported studies on 
AMPK activation validation utilized liver cells of rodents or other mammalian model 
and this study showed that C. elegans can also be applied for such studies. These are 
advantageous factors for bioactivity screening endeavor as it expands the scope of worm 
application in multiple assays beyond preliminary screen. Promising candidate 
compounds can be further validated in mammalian models at a later stage and could 
thereby bring down the cost of drug development due to the economical benefits in 
using a worm model. In this study, berberine and sanguinarine were found to have lipid-
reducing activity which is linked to the AMPK activation. This activity was dependent 
on AAK-2, the C. elegans homologs of the catalytic -subunits of AMPK. On the other 
hand, experiment using nhr-49 RNAi worms showed that the lipid reduction activity of 
both alkaloids act independently from nhr-49 regulated fatty acid -oxidation process. 
Furthermore, RNAi control worms treated with berberine and sanguinarine showed 
reduced nhr-49 expression which suggests that they have antagonistic effect on lipid 
synthesis and degradation processes. However, these alkaloids predominantly affect 
lipid synthesis instead of fatty acid –oxidation process leading to the overall lipid 
reduction observed in the worms. 
Although both berberine and sanguinarine reduced lipid accumulation in C. elegans, 
several different characteristics of the two alkaloids were noted. Berberine, a protopine-
type of alkaloid, required a relatively high effective dosage (500 M) for its lipid-
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reducing activity. The phosphorylation level of the worm’s AMPK -subunit was 
weaker with berberine compared to sanguinarine after 24 h treatment. On the other hand, 
sanguinarine, a benzophenanthridine-type of alkaloid, showed more potent lipid-
reducing activity with an effective dosage at 25 M. Stronger AMPK -subunit 
phosphorylation activity was observed with sanguinarine-treated worm after 24 h. 
In Chapter II, the established assay was extended to evaluate the effects of mixed 
secondary metabolites in plant cell cultures on lipid reduction. The results showed that 
C. japonica cell culture extract which contains berberine as major component had 
stronger lipid reducing activity than berberine at similar concentration. On the other 
hand, E. californica cell culture extract with its major component sanguinarine showed 
weaker activity than in single compound treatment. This shows that cell extracts contain 
both synergistic and antagonistic components that may lead to differences in the 
bioactivity strength compared to single alkaloids. In addition to single compound, 
mixtures also possess bioactivities that are pertinent to new drug development. This 
simple comparison of pure compounds and crude cell extracts would be useful to 
characterize the bioactive composition in natural medicine. The rapid advancement in 
the fields of plant metabolic engineering and synthetic biology would supply more 
potent materials for the development of new medicine (Sato et al., 2001; Minami et al, 
2008). 
In Chapter III, I developed a more sensitive C. elegans bioassay system since this 
worm has extensive physical, such as its thick cuticle, and molecular (detoxification 
enzymes) defense mechanisms against xenobiotics. Although the effective dose of test 
compounds in worm was at higher orders of magnitude than that in mammalian cell 
culture (Kwok et al., 2006; Broeks et al., 1995), nhr-8 RNAi worms were found to be 
more susceptible to the lipid reduction effects of some isoquinoline alkaloids, especially 
berberine which showed increased sensitivity by 8-fold. Increased sensitivity to alkaloid 
treatment in nhr-8 RNAi worms suggests that such detoxification mechanism may be 
impeded. However, the major upregulated detoxification genes were found not impeded, 
except for ugt-21 which could be a target of NHR-8. This nhr-8 RNAi worms would be 
especially useful for screening of complex plant alkaloids whereby the amount isolated 
for testing are scarce. 
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This collective studies show that C. elegans is a versatile, whole organism probe for 
isoquinoline alkaloids bioactivities screening. Using this worm bioassay system, the 
potent lipid modulation activity in certain classes of alkaloids and the probable action 
mechanisms were revealed. The established assays could be extended to screen 
bioactivities of more structurally diverse alkaloids as well as mixture of plant 
metabolites in cell cultures in the future. This live worm model also enables concurrent 
monitoring of the alkaloids’ toxic effect. Such bioassay system is useful for new drug 
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